News Focus
News Focus
icon url

JRoon71

03/03/25 11:28 AM

#433484 RE: rosemountbomber #433479

I still think this is a sad commentary on the medical community. Isn't it their jobs to treat patients. Has that responsibility morphed into awaiting marketing campaigns to guide their treatment protocols?



Look at the guidelines, and look at what is covered by insurance. We can't place all the blame on doctors. Spend some time reading opinions on Vascepa within the healthcare industry. Most of what I see is "well, it's really just fish oil...it's for high trigs...bad placebo...". Plus, when you've got statins, PCSK9, Ezetimibe, and BA, there is not really a "need" for another solution. Look at how EZE+BA combo pill is doing in the UK compared to Vazkepa.

Most docs have their "go-to" authorities in the industry. And if they follow someone like Nissen (and there are many others), then they will have a natural skepticism towards Vascepa and fish oil in general.

The fact is, Amarin stopped trying in the U.S. years ago. New Medications don't just "sell themselves". You think GLP-1's just "magically" fly off the shelves? No. Their companies SELL them. They MARKET them. You can't watch TV for 5 minutes without seeing a commercial for them.
icon url

Whalatane

03/03/25 1:37 PM

#433488 RE: rosemountbomber #433479

RMB Insurance co pays ...or lack of coverage ...ultimately determine which drugs patients get or can afford .
Some drug companies set unreasonably high prices for their drugs and health providers use tier ratings to make patient copays unaffordable for many .
As example ...my Cardiologist will prescribe me Inclisiran ( a PCSK9 thats 2 shots a year ) but Kaiser insists I pay the full amount ...around $6,000 a year if I want it , or stick with Repatha ( a shot every 2 wks ) which they will cover with a $1,500 a yr co pay .
For CKD patients , as you are aware , Insurers usually want LN patients to fail on Benlysta before they will consider covering Lupkynis ...Benlysta being around 1/3 rd less cost .
MD's usually try to treat their patients with the best drugs available ...wether insurers will cover them is a whole different matter .

Treatment protocols are often driven by the heads of the various departments in hospitals . So if you have a head of dept thats a fan of Dr Nissen ...dont expect a huge push to prescribe Vascepa

Kiwi